JEONJINBIO CEO Taehoon Lee Plans to Buy 300 Million KRW in Shares for Price Stabilization, Strengthening Responsible Management and Shareholder Value
JEONJINBIO CEO Taehoon Lee, who has purchased approximately 86,940 common shares in the open market over the past six months prior to the reporting date, announced a plan to acquire an additional 169,492 shares worth about 300 million KRW from July 21 to August 19, 2026.
The purpose of this purchase is to stabilize the stock price and strengthen responsible management. The purchase price is set at 1,770 KRW, the closing price on the last trading day before the report submission. Upon completion, Lee's stake will rise from 4.44% to 6.31% of total outstanding shares.
This voluntary increase in insider ownership sends a positive signal of confidence to the market and may support the short-term stock price. However, actual transaction volume may vary between 70% and 130% of the planned amount.
[AI Summary]The CEO's planned open market share purchase is a positive step to enhance shareholder value and management stability. The additional 1.87% stake acquisition boosts minority investor confidence and is expected to defend against short-term price declines. However, this is a personal investment and does not reflect a change in the company's fundamentals.
KOSDAQ Filing Information
Report On Transaction Plan Of Specific Securities By Executives And Major Shareholders